Efgartigimod alfa and hyaluronidase (human recombinant)
- Part D specialty tier in 76% of formularies (2026Q3)
- Biologic
- VYVGART Hytrulo
Therapy management checklist
Screening, baseline and ongoing monitoring with the label's stated frequency, hold and discontinue criteria, and counseling points, each quoted from the FDA label.
Loading the therapy management checklist…
Storage and cold chain
Efgartigimod alfa and hyaluronidase (human recombinant): storage and handling
- Refrigerate
- Yes, as the label states
Label statement
Store VYVGART HYTRULO vials refrigerated at 2°C to 8°C (36°F to 46°F) in the original carton to protect from light until time of use.
- Freezing
- Do not freeze
Label statement
Do not freeze.
- Room temperature
- up to 3 days at or below 25°C (77°F)
Label statement
If needed, unopened vials may be stored in the original carton for up to 3 days at room temperature at 20°C to 25°C (68°F to 77°F) for a single period before administration or returned to refrigeration.
- Room temperature
- up to 30 days at or below 30°C (86°F)
Label statement
If needed, prefilled syringes may be stored at room temperature at up to 30°C (86°F) in the original carton for a single period of up to 30 days after removing from refrigerator or until expiration date on the carton, whichever occurs first.
- Room temperature
- up to 30 days at or below 30°C (86°F)
Label statement
Single-dose prefilled syringe may be stored at room temperature (up to 86°F (30°C)) for up to 30 days.
- Room temperature
- up to 30 days
Label statement
When removed from the refrigerator and brought to room temperature VYVGART HYTRULO must be used within 30 days or thrown away.
- Room temperature
- up to 3 days at or below 25°C (77°F)
Label statement
Single-dose vial may be stored at room temperature (between 68°F to 77°F (20°C to 25°C)) for up to 3 days.
- Room temperature
- up to 3 days
Label statement
When removed from the refrigerator and brought to room temperature, VYVGART HYTRULO must be used within 3 days or thrown away.
- Back into the refrigerator
- Not addressed
- Light
- Protect from light
Label statement
Store VYVGART HYTRULO vials refrigerated at 2°C to 8°C (36°F to 46°F) in the original carton to protect from light until time of use.
- Shaking
- Do not shake
Label statement
Do not shake.
All storage statements on the label (34)
- Store VYVGART HYTRULO vials refrigerated at 2°C to 8°C (36°F to 46°F) in the original carton to protect from light until time of use.
- Do not freeze.
- Do not shake.
- If needed, unopened vials may be stored in the original carton for up to 3 days at room temperature at 20°C to 25°C (68°F to 77°F) for a single period before administration or returned to refrigeration.
- Do not store the vial at room temperature more than one time.
- Record the date removed from and the date returned to the refrigerator on the carton.
- Store VYVGART HYTRULO prefilled syringe refrigerated at 2°C to 8°C (36°F to 46°F) in the original carton to protect from light until time of use.
- If needed, prefilled syringes may be stored at room temperature at up to 30°C (86°F) in the original carton for a single period of up to 30 days after removing from refrigerator or until expiration date on the carton, whichever occurs first.
- Record the date removed from the refrigerator on the carton.
- Storing VYVGART HYTRULO Prefilled Syringe Store VYVGART HYTRULO in the refrigerator between 36°F to 46°F (2°C to 8°C) (see Figure A ).
- Keep the prefilled syringes in the original carton to protect them from light until ready to use.
- Do not freeze the prefilled syringes or store them in direct sunlight.
- Do not use a prefilled syringe that has been frozen or left in direct sunlight.
- Prefilled Syringe Parts Safety Needle (not provided with VYVGART HYTRULO prefilled syringe) that is 25G, 5/8 inch length, thin wall Gather and Check the Prefilled Syringe 1 Remove the carton from the refrigerator
- Remove the carton containing the prefilled syringe from the refrigerator (see Figure C ).
- Remove 1 prefilled syringe from the carton (see Figure D ) and place any remaining prefilled syringes back into the refrigerator for later use.
- Check the expiration date on the prefilled syringe label (see Figure F ).
- Do not use the prefilled syringe if the expiration date has passed.
- Refrigerated Store VYVGART HYTRULO in the refrigerator between 36°F to 46°F (2°C to 8°C).
- Warm VYVGART HYTRULO by letting it sit on a flat surface for at least 30 minutes for the prefilled syringe and 15 minutes for the vial.
- Do not warm VYVGART HYTRULO any other way (e.g., with an external heat source).
- Store VYVGART HYTRULO in the original carton to protect from light until you are ready to use it.
- Do not freeze VYVGART HYTRULO.
- Do not shake VYVGART HYTRULO.
- Do not use VYVGART HYTRULO past the expiration date.
- Remove from the refrigerator only the dose you are preparing to inject.
- Future doses should remain refrigerated until ready to use.
- Room temperature If needed, VYVGART HYTRULO may be stored at room temperature.
- Record the date you removed VYVGART HYTRULO from the refrigerator.
- Single-dose prefilled syringe may be stored at room temperature (up to 86°F (30°C)) for up to 30 days.
- When removed from the refrigerator and brought to room temperature VYVGART HYTRULO must be used within 30 days or thrown away.
- Single-dose vial may be stored at room temperature (between 68°F to 77°F (20°C to 25°C)) for up to 3 days.
- When removed from the refrigerator and brought to room temperature, VYVGART HYTRULO must be used within 3 days or thrown away.
- Do not put VYVGART HYTRULO back into the refrigerator after it has warmed to room temperature.
FDA label version 13, effective July 15, 2026. DailyMed
Dosing and titration calendar
Built only from the schedules the label states (loading, titration, day schedules, cycles and weight bands). Steps the label states in words the calendar cannot place are shown, not guessed.
Loading dosing schedules…
Medicare Part D coverage
5,496 Part D plans, CMS formulary files 2026Q3. Look up tier, PA, step therapy and quantity limits by plan
Patient assistance
No manufacturer program page is listed for this drug yet.
Independent foundations and the full directory (checked 2026-11-06). Eligibility and amounts are set by each program; open its page for them.
For licensed clinicians. Use with clinical judgment. Statements are quoted from the FDA label; confirm against the label for the product you are using.